Life Science Outsourcing, Inc., a leading contract manufacturer and value-added service provider to medical device and life science companies, announced today that it has acquired J-Pac Medical, a manufacturing, packaging and sterilization outsourcing partner to medical device and diagnostic companies.
The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.
Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.
The Controlled Environmental Solutions business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.
